These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 4103749

  • 1. Thyroidal effects of injections of Graves' disease thyroid microsomes in rhesus monkeys.
    Furth ED, Dentinger M.
    Endocrinology; 1971 Jul; 89(1):310-5. PubMed ID: 4103749
    [No Abstract] [Full Text] [Related]

  • 2. Comparative effects of immunization of rabbits with human thyroglobulin and human and rabbit thyroid microsomal fractions.
    Beall GN, Chopra IJ, Solomon DH.
    Clin Exp Immunol; 1971 Apr; 8(4):647-56. PubMed ID: 5576294
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Relationship between the long-acting thyroid stimulator and circulating thyroid antibodies in Graves' disease.
    Pinchera A, Liberti P, De Santis R, Grasso L, Martino E, Baschieri L.
    J Clin Endocrinol Metab; 1967 Dec; 27(12):1758-60. PubMed ID: 6072765
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Thyroid gland in Graves' disease: victim or culprit?
    Chopra IJ, Solomon DH, Johnson DE, Chopra U.
    Metabolism; 1970 Oct; 19(10):760-72. PubMed ID: 5535910
    [No Abstract] [Full Text] [Related]

  • 7. Experimental production of a thyroid-stimulating antithyroid antibody.
    McKenzie JM.
    J Clin Endocrinol Metab; 1968 May; 28(5):596-602. PubMed ID: 4172455
    [No Abstract] [Full Text] [Related]

  • 8. [Simultaneous study of LATS and antimicrosomial antibodies in untreated Basedow's disease].
    Orgiazzi J, Pousset G, Durand H.
    Presse Med (1893); 1971 May 22; 79(25):1167-8. PubMed ID: 4933634
    [No Abstract] [Full Text] [Related]

  • 9. Suppressibility of thyroid function despite high levels of long-acting thyroid stimulator.
    Wong ET, Doe RP.
    Ann Intern Med; 1972 Jan 22; 76(1):77-84. PubMed ID: 4112158
    [No Abstract] [Full Text] [Related]

  • 10. On the interaction of long-acting thyroid stimulator with thyroid microsomes.
    Burke G.
    J Clin Endocrinol Metab; 1967 Aug 22; 27(8):1095-102. PubMed ID: 4166580
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Absence of thyroid-stimulating antibody and long acting thyroid stimulator in relatives of Graves' disease patients.
    Banovac K, Zakarija M, McKenzie JM, Witte A, Sekso M.
    J Clin Endocrinol Metab; 1981 Sep 22; 53(3):651-3. PubMed ID: 6790561
    [Abstract] [Full Text] [Related]

  • 14. Heterogeneity of long acting thyroid stimulating (LATS)-activity, thyroglobulin antibodies and thyroid microsomal antibodies.
    Adlkofer F, Schleusener H, Uher L, Ananos A.
    Acta Endocrinol (Copenh); 1973 Jul 22; 73(3):483-8. PubMed ID: 4740843
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Triiodothyronine, thyroxine, and iodine in purified thyroglobulin from patients with Graves' disease.
    Izumi M, Larsen PR.
    J Clin Invest; 1977 Jun 22; 59(6):1105-12. PubMed ID: 577211
    [Abstract] [Full Text] [Related]

  • 17. On the mechanism of the McKenzie bioassay.
    Florsheim WH, Williams AD, Schönbaum E.
    Endocrinology; 1970 Nov 22; 87(5):881-8. PubMed ID: 5536603
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.